tiprankstipranks
Trending News
More News >
Advertisement

IL:IS.FF402 ETF Technical Analysis

Compare

Summary of all the Indicators

Summary
Strong Buy
16Bullish
0Neutral
5Bearish
Oscillators
Sell
4Bullish
0Neutral
5Bearish
Moving Averages
Strong Buy
12Bullish
0Neutral
0Bearish
iShares Healthcare Innovation UCITS ETF’s (IS.FF402) Moving Averages Convergence Divergence (MACD) indicator is 15.35, suggesting iShares Healthcare Innovation UCITS ETF is a Sell.
iShares Healthcare Innovation UCITS ETF’s (IS.FF402) 20-Day exponential moving average is 2630.72, making it a Buy.
iShares Healthcare Innovation UCITS ETF’s (IS.FF402) 50-Day exponential moving average is 2619.61, making it a Buy.

iShares Healthcare Innovation UCITS ETF (IS.FF402) Pivot Points

Aug 24, 2025, 06:00 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
2,498.67
2,557.33
2,611.67
2,670.33
2,724.67
2,783.33
2,837.67
Fibonacci
2,557.33
2,600.50
2,627.17
2,670.33
2,713.50
2,740.17
2,783.33

iShares Healthcare Innovation UCITS ETF (IS.FF402) Moving Averages

Aug 24, 2025, 06:00 AM
Period
Simple
Exponential
MA5
2,649.00Buy
2,665.30Buy
MA10
2,628.30Buy
2,645.13Buy
MA20
2,637.45Buy
2,630.72Buy
MA50
2,609.50Buy
2,619.61Buy
MA100
2,610.08Buy
2,642.94Buy
MA200
2,716.95Buy
2,730.46Buy
iShares Healthcare Innovation UCITS ETF’s (IS.FF402) 10-Day exponential moving average is 2645.13, making it a Buy.
iShares Healthcare Innovation UCITS ETF’s (IS.FF402) 100-Day exponential moving average is 2642.94, making it a Buy.
iShares Healthcare Innovation UCITS ETF’s (IS.FF402) 50-day simple moving average is 2609.50, creating a Buy signal.
iShares Healthcare Innovation UCITS ETF’s (IS.FF402) 100-day simple moving average is 2610.08, creating a Buy signal.
iShares Healthcare Innovation UCITS ETF’s (IS.FF402) 200-day simple moving average is 2716.95, creating a Buy signal.

iShares Healthcare Innovation UCITS ETF (IS.FF402) Technical Analysis

Aug 24, 2025, 06:00 AM
Name
Value
Action
RSI (14)
77.23
Sell
STOCH (9,6)
99.23
Sell
STOCHRSI (14)
99.23
Sell
MACD (12,26)
15.35
Sell
ADX (14)
6.15
Buy
Williams %R
0.00
-
CCI (14)
118.20
Sell
ATR (14)
1,728.73
-
Ultimate Oscillator
99.55
Buy
ROC
2.79
Buy
iShares Healthcare Innovation UCITS ETF’s (IS.FF402) Relative Strength Index (RSI) is 77.23, creating a Sell signal.
iShares Healthcare Innovation UCITS ETF’s (IS.FF402) Trend Strength Indicator (ADX) is 6.15, creating a Buy signal.
iShares Healthcare Innovation UCITS ETF’s (IS.FF402) Commodity Channel Index (CCI) is 118.20, creating a Sell signal.
iShares Healthcare Innovation UCITS ETF’s (IS.FF402) Price Rate of Change (ROC) is 2.79, creating a Buy signal.

FAQ

Is IS.FF402 a Buy, Hold, or Sell?
Based on IS.FF402’s technical indicators, IS.FF402 is a Strong Buy.
    What is IS.FF402’s RSI (14)?
    IS.FF402’s RSI (14) is 77.23, which suggests IS.FF402 is a Sell.
      What is IS.FF402’s MACD?
      IS.FF402’s MACD is 15.35, which suggests IS.FF402 is a Sell.
        What is IS.FF402’s 5-day moving average?
        IS.FF402’s 5-day moving average is 2649.00, which suggests IS.FF402 is a Buy.
          What is IS.FF402’s 20-day moving average?
          IS.FF402 20-day moving average is 2637.45, which suggests IS.FF402 is a Buy.
            What is IS.FF402’s 50-day moving average?
            IS.FF402’s 50-day moving average is 2609.50, which suggests IS.FF402 is a Buy.
              What is IS.FF402’s 200-day moving average?
              IS.FF402’s 200-day moving average is 2716.95, which suggests IS.FF402 is a Buy.
                What is IS.FF402’s Williams % R (14)?
                Currently, no data Available
                What is IS.FF402’s CCI (14)?
                IS.FF402’s CCI (14) is 118.20, which suggests IS.FF402 is a Sell.
                  What am I Missing?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis
                  Advertisement